2023-09-01T03:41:09+03:00[Europe/Moscow] en true <p>&lt;120; &lt;80</p>, <p>120-129; &lt;80</p>, <p>130-139; 80-89</p>, <p>&gt;140; &gt;90</p>, <p>if &gt;20/10mmHg</p>, <p>need ASCVD risk; may or may not start medication; more aggressive treatment/follow up</p>, <p>pulmonary disease, valvular heart disease, ED, PAD/PVD, heart block/ bradycardia </p>, <p>b, c</p>, <p>d</p>, <p>g</p>, <p>ACEI or ARB + thiazide; ACEI or ARB + CCB</p>, <p>ACEI + ARB</p>, <p>carbonic anhydrase inhibitors, osmotic diuretics </p>, <p>acetazoldamide, dorzolamide</p>, <p>mannitol </p>, <p>f; must combine w/ other BP medication</p>, <p>significant CKD w GFR&lt; 40 ml/min</p>, <p>increased risk of hyperkalemia; we are blocking aldosterone; less Na+ uptake into the cell; less excretion of potassium</p>, <p>treatment-resistant, ckd; GFR &lt;30ml/min, hyponatremic patients</p>, <p>primary aldosteronism, heart failure, resistant HTN</p>, <p>low Na+ diet, Caucasians, patients w low renin levels </p>, <p>african americans, chronic NSAID users</p>, <p>pregnancy, bilateral renal artery stenosis</p>, <p>aliskiren, increased lithium serum concentrations, potassium-sparing diuretics, direct renin inhibitors </p>, <p>increase in SrCr of at least 30%</p>, <p>c</p>, <p>false; less than 1%</p>, <p>6 weeks</p>, <p>on a thiazide, volume-depleted, elderly; risk of hypotension</p>, <p>don't crush up oral pellets; take with milk or water</p>, <p>heart failure w/ reduced EF, stable ischemic heart disease, Acute coronary syndrome, diabetes, CKD</p>, <p>angioedema, pregnancy, rash</p>, <p>methyldopa, nifedipine, labetalol</p>, <p>b, f</p>, <p>b</p>, <p>c</p>, <p>d</p>, <p>b, e</p>, <p>ACEi or ARB + BB</p>, <p>CCB + diuretic</p>, <p>d</p>, <p>dofetilide, sotalol, droperidol</p>, <p>lithium</p>, <p>digoxin</p>, <p>increases; electrolyte </p>, <p>decrease efficacy </p>, <p>c</p>, <p>d,e</p>, <p>e</p>, <p>a</p>, <p>a, c</p>, <p>b</p>, <p>a</p>, <p>d</p>, <p>SBP-DBP; 40-60</p>, <p>structure changes/ Afib</p>, <p>poor heart function, low CO</p>, <p>(SBP x 1/3) + (DBP x 2/3) ; 70-100</p>, <p>increased risk of blood clots, CVA, HF</p>, <p>low perfusion to brain/kidneys</p>, <p>Mean arterial pressure</p>, <p>pulse pressure</p>, <p>elevated bp, 4th heart sound, av nicking, cardiomyopathy, carotid bruits</p>, <p>headache, fatigue, dizziness, facial flushing</p>, <p>2-3 measurements over 2-3 visits </p>, <p>false</p>, <p>b</p>, <p>sleep deficits, heavy drinking, physical inactivity, smoking, perceived health</p> flashcards
HTN Therapeutics: Diuretics & ACEI/ARBs

HTN Therapeutics: Diuretics & ACEI/ARBs

  • <120; <80

    What is the SBP & DBP for "Normal Patients" ?

  • 120-129; <80

    What is the SBP & DBP for " Prehypertension"?

  • 130-139; 80-89

    What is the SBP & DBP for "HTN- Stage 1"?

  • >140; >90

    What is the SBP & DBP for "HTN-Stage 2"?

  • if >20/10mmHg

    When do we start a Stage 2: HTN patient on 2 different medications?

  • need ASCVD risk; may or may not start medication; more aggressive treatment/follow up

    What are the clinical guidelines for a Stage 1: HTN patient?

  • pulmonary disease, valvular heart disease, ED, PAD/PVD, heart block/ bradycardia

    Which disease states do we avoid Beta-blockers in? (5)

  • b, c

    Which disease states do we avoid non-DHP CCBs?

    a) Pulmonary disease

    b) heart failure

    c) valvular heart disease

    d) erectile dysfunction

    e) PAD/PVD

    f) Heart block/ Bradycardia

    g) Pregnancy

  • d

    Which disease states do we avoid aldosterone antagonists?

    a) Pulmonary disease

    b) heart failure

    c) valvular heart disease

    d) erectile dysfunction

    e) PAD/PVD

    f) Heart block/ Bradycardia

    g) Pregnancy

  • g

    Which disease state do we avoid ACEIs and ARBs?

    a) Pulmonary disease

    b) heart failure

    c) valvular heart disease

    d) erectile dysfunction

    e) PAD/PVD

    f) Heart block/ Bradycardia

    g) Pregnancy

  • ACEI or ARB + thiazide; ACEI or ARB + CCB

    What are the preferred medication combos for HTN?

  • ACEI + ARB

    Which medication combo do we avoid in HTN?

  • carbonic anhydrase inhibitors, osmotic diuretics

    Which diuretics are not useful for HTN?

  • acetazoldamide, dorzolamide

    What are the carbonic anhydrase inhibitors? (2)

  • mannitol

    What is the Osmotic diuretic?

  • f; must combine w/ other BP medication

    Potassium-sparing Diuretics are effective as standalone therapies. T/F?

  • significant CKD w GFR< 40 ml/min

    When do we avoid Potassium-sparing diuretics?

  • increased risk of hyperkalemia; we are blocking aldosterone; less Na+ uptake into the cell; less excretion of potassium

    Why are Potassium-sparing diuretics a bad combo in RAAS or aldosterone antagonists? Why?

  • treatment-resistant, ckd; GFR <30ml/min, hyponatremic patients

    Which types of patients are Loop Diuretics reserved for? (3)

  • primary aldosteronism, heart failure, resistant HTN

    Spironolactone & Eplerenone are preferred agents in patients who possess what conditions? (3)

  • low Na+ diet, Caucasians, patients w low renin levels

    Which patients have a better response to ACEI/ARBs? (3)

  • african americans, chronic NSAID users

    Which patients have an attenuated response to ACEI/ARBS? (2)

  • pregnancy, bilateral renal artery stenosis

    When do we NOT use ACEI/ARBS? (2)

  • aliskiren, increased lithium serum concentrations, potassium-sparing diuretics, direct renin inhibitors

    Which DDI's should we watch out for when prescribing ACEI/ARBs?

  • increase in SrCr of at least 30%

    How do we monitor for renal artery stenosis in patients on ACEI/ARBs?

  • c

    There are no renal dose adjustments in _______.

    a) thiazides

    b) ACEi

    c) ARBs

    d) Aliskiren

  • false; less than 1%

    The cross-reactivity of ACEI and ARBs is high. T/F?

  • 6 weeks

    If you stop an ACEi for angioedema cross-reactivity, how long should you wait before starting an ARB?

  • on a thiazide, volume-depleted, elderly; risk of hypotension

    Starting doses for ACEI/ARBs should be reduced by 50% in patients who are what? Why?

  • don't crush up oral pellets; take with milk or water

    Counseling points for Aliskiren (2) ?

  • heart failure w/ reduced EF, stable ischemic heart disease, Acute coronary syndrome, diabetes, CKD

    What are Compelling Indications for ACEI & ARB use? (5)

  • angioedema, pregnancy, rash

    Which AE's do we discontinue ACEi/ARBs? (3)

  • methyldopa, nifedipine, labetalol

    Which Medications do we use in pregnancy? (3)

  • b, f

    Which medications do we AVOID in Valvular Heart disease?

    a) methyldopa

    b) beta blocker

    c) Losartan

    d) Alpha blocker

    e) ARB

    f) non-DHP CCB

  • b

    Which medication is the treatment of choice in Thoracic Aortic Aneurysms?

    a) methyldopa

    b) beta blocker

    c) Losartan

    d) Alpha blocker

    e) ARB

    f) non-DHP CCB

  • c

    Which medication is the treatment of choice for gout?

    a) methyldopa

    b) beta blocker

    c) Losartan

    d) Alpha blocker

    e) ARB

    f) non-DHP CCB

  • d

    Which medication is the medication of choice for Benign Prostatic Hyperplasia?

    a) methyldopa

    b) beta blocker

    c) Losartan

    d) Alpha blocker

    e) ARB

    f) non-DHP CCB

  • b, e

    Which medication is used for Afib?

    a) methyldopa

    b) beta blocker

    c) Losartan

    d) Alpha blocker

    e) ARB

    f) non-DHP CCB

  • ACEi or ARB + BB

    What is the HTN-medication combo for Caucasians?

  • CCB + diuretic

    What is the HTN-medication combo for African Americans?

  • d

    Which diuretic is used in Heart failure patients?

    a) osmotic

    b) thiazide

    c) potassium sparing

    d) loop

    e) AA/MRAs

  • dofetilide, sotalol, droperidol

    A patient on thiazide diuretics + _____ = increased risk of arrythmias. (3)

  • lithium

    A patient on thiazide diuretics + _____ = lithium toxicity

  • digoxin

    A patient on thiazide diuretics + ______ = digoxin toxicity

  • increases; electrolyte

    Combining diuretics ________ risk of various _________ abnormalities.

  • decrease efficacy

    NSAIDs _________ of thiazides.

  • c

    Which thiazide may have some effect on Ca++ blockade?

    a) HCTZ

    b) chlorothalidone

    c) indapamide

    d) metalozone

  • d,e

    Which diuretics do we have to watch K+ & SrCR?

    a) osmotic

    b) thiazide

    c) potassium sparing

    d) loop

    e) MRAs

  • e

    Which ACEi is the only "true once daily"?

    a) Captopril

    b) Enalapril

    c) Lisinopril

    d) Moexipril

    e) Trandolapril

  • a

    Which ACEi do we watch for Sulfa allergies?

    a) Captopril

    b) Enalapril

    c) Lisinopril

    d) Moexipril

    e) Trandolapril

  • a, c

    Which ACEi is NOT a prodrug?

    a) Captopril

    b) Enalapril

    c) Lisinopril

    d) Moexipril

    e) Trandolapril

  • b

    Which is the only available via IV?

    a) Captopril

    b) Enalapril

    c) Lisinopril

    d) Moexipril

    e) Trandolapril

  • a

    Which is required to be taken 2-3x/ day?

    a) Captopril

    b) Enalapril

    c) Lisinopril

    d) Moexipril

    e) Trandolapril

  • d

    Which is required to be taken with food to increase absorption?

    a) Captopril

    b) Enalapril

    c) Lisinopril

    d) Moexipril

    e) Trandolapril

  • SBP-DBP; 40-60

    The formula for Pulse Pressure? Normal range?

  • structure changes/ Afib

    High pulse pressure =

  • poor heart function, low CO

    Low pulse pressure =

  • (SBP x 1/3) + (DBP x 2/3) ; 70-100

    MAP formula? Normal range?

  • increased risk of blood clots, CVA, HF

    High MAP =

  • low perfusion to brain/kidneys

    Low MAP =

  • Mean arterial pressure

    -average pressure throughout the cardiac cycle

  • pulse pressure

    - a measure of arterial wall tension

  • elevated bp, 4th heart sound, av nicking, cardiomyopathy, carotid bruits

    Signs of Hypertension (5)

  • headache, fatigue, dizziness, facial flushing

    Symptoms of HTN (4)

  • 2-3 measurements over 2-3 visits

    Diagnosis of HTN?

  • false

    CVD risk is equal in White-Coat HTN and Masked-HTN. T/F?

  • b

    Do we treat a patient who has White-Coat HTN with a normal BP reading at home?

    a) yes

    b) no

  • sleep deficits, heavy drinking, physical inactivity, smoking, perceived health

    Incidence-impacting factors? (5)